Page last updated: 2024-08-17

anthrone and anthralin

anthrone has been researched along with anthralin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gawlik, I; Huang, HS; Müller, K; Prinz, H; Ziereis, K1
Breu, K; Müller, K; Reindl, H1
Ehmann, CW; Lowe, N; Patel, BG; Wang, JC1
Müller, K; Wiegrebe, W1
MUHLEMANN, H1
Majerz, I; Szymańska, M1

Reviews

1 review(s) available for anthrone and anthralin

ArticleYear
Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
    Skin pharmacology : the official journal of the Skin Pharmacology Society, 1995, Volume: 8, Issue:1-2

    Topics: Anthracenes; Anthralin; Drug Design; Humans; Lipid Peroxidation; Lipoxygenase Inhibitors; Psoriasis; Reactive Oxygen Species

1995

Other Studies

5 other study(ies) available for anthrone and anthralin

ArticleYear
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
    Journal of medicinal chemistry, 1997, Nov-07, Volume: 40, Issue:23

    Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonate 5-Lipoxygenase; Cattle; Cell Division; Humans; Keratinocytes; Leukocytes, Mononuclear; Lipoxygenase Inhibitors; Oxidants; Psoriasis; Sensitivity and Specificity; Structure-Activity Relationship

1997
Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
    Journal of medicinal chemistry, 2001, Mar-01, Volume: 44, Issue:5

    Topics: Acetanilides; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Division; Cell Line; Cell Membrane; Humans; Keratinocytes; Leukotriene B4; Oxidation-Reduction; Psoriasis; Structure-Activity Relationship

2001
The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin.
    Journal of the American Academy of Dermatology, 1987, Volume: 16, Issue:4

    Topics: Anthracenes; Anthralin; Anthraquinones; Humans; In Vitro Techniques; Psoriasis; Skin Absorption

1987
[Anthrone and anthranol glycoside].
    Pharmaceutica acta Helvetiae, 1949, Oct-29, Volume: 24, Issue:10

    Topics: Anthracenes; Anthralin; Cardiac Glycosides; Glucosides; Glycosides

1949
Prototropy, Intramolecular Interactions, Electron Delocalization, and Physicochemical Properties of 1,8-dihydroxy-9-anthrone-DFT-D3 Study of Substituent Effects.
    Molecules (Basel, Switzerland), 2023, Jan-01, Volume: 28, Issue:1

    Topics: Alcohols; Anthracenes; Anthralin; Electrons; Ketones; Protons

2023